| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Alexander K. Arrow last filed a Form 4 in March 2024, as Chief Financial Officer at PTIX. Alexander K. Arrow's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Alexander K. Arrow's trades have earned a below-average insider score of 29/100 across 5 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -45.1%.
At the last filing, the largest reported position was 45,815 shares of PTIX. Net of sales, the PTIX filings show accumulation of 41,000 shares.
Alexander K. Arrow has 13 Form 4 filings on record from April 2016 to March 2024, all as Chief Financial Officer at Protagenic Therapeutics, Inc.\new (PTIX), 2016–2024.
The 18 reported transactions were 12 open-market purchases, 5 option or other derivative awards and 1 stock award.
Counted by filing, the open-market trades come to 3 purchases worth about $33K and no sales.
The largest open-market purchase was 31,000 shares of PTIX at an average $0.71 on May 18, 2022, about $22K. Twelve months later PTIX was down 35%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2023 | PTIX Protagenic Therapeutics, Inc.\new | Chief Financial Officer | Buy | 8,000 | $0.81 | $6,480.00 | +21.2% | +21.7% | -31.0% | |
| May 18, 2022 | PTIX Protagenic Therapeutics, Inc.\new | Chief Financial Officer | Buy | 31,000 | $0.71 | $22,090.00 | +25.8% | -13.9% | -35.0% | |
| Apr 30, 2021 | PTIX Protagenic Therapeutics, Inc.\new | Chief Financial Officer | Buy | 2,000 | $2.29 | $4,580.00 | +1.7% | -1.3% | -63.8% |